Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veverimer in CKD and metabolic acidosis
NCT02809183Phase 2Completed
- Sponsor
- Tricida, Inc.
- Start
- Mar 2016
- Primary completion
- Nov 2016
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of veverimer in metabolic acidosis, sponsored by Tricida, Inc.. Started Mar 2016; status: completed.
02
Drugs
veverimer
03
Conditions
metabolic acidosis
Beyond the preview
Go deeper on NCT02809183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809183.